Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Published on 13/10/202513/10/2025 by Research Hypothesis

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award

Assoc. Prof. Dr. Mar Jimenez de la Pena | Medicine and Health Sciences | Medical Hypothesis Award | Radiologist | University Hospital Quironsalud Madrid | Spain

Assoc. Prof. Dr. Mar Jimenez de la Pena is a highly accomplished radiologist and academician with a distinguished career devoted to advancing diagnostic imaging, neuroimaging, and translational radiology. She completed her Licentiate in Medicine and Surgery at the Universidad Complutense de Madrid and specialized in Radiodiagnosis at Hospital 12 de Octubre in Madrid, establishing a robust clinical and scientific foundation. Currently serving as the Associate Head of Diagnostic Imaging at Hospital Universitario QuirónSalud Madrid, she also contributes as a Professor of Medicine at the Universidad Europea de Madrid, where she mentors medical students and radiology residents. Her professional experience spans more than two decades, encompassing academic instruction, clinical excellence, and leadership in medical imaging. Assoc. Prof. Dr. Mar Jimenez de la Pena has been actively engaged in national and international research collaborations, focusing on the application of advanced MRI techniques in neurological disorders, pediatric neuroimaging, and genetic syndromes. Her research interests center on neurodevelopmental disorders, brain perfusion analysis, and the application of artificial intelligence in MRI interpretation. She has demonstrated outstanding research skills in multimodal MRI data acquisition, neuroimage analysis, and clinical study design. Her work has been published in top-tier journals such as Frontiers in Neuroscience, Neuroradiology, European Journal of Medical Genetics, and American Journal of Medical Genetics Part A, significantly contributing to the understanding of complex neuroimaging patterns and clinical correlations. With over 40 peer-reviewed articles, including 33 international papers, and multiple book chapters, she has established a strong academic footprint. Assoc. Prof. Dr. Mar Jimenez de la Pena has received over 30 prestigious awards, including 29 honors from the Spanish Society of Radiology (SERAM), recognition from the Spanish Society of Neurosurgery (SENR), and an American Society of Radiology Award for her scientific presentations. Her memberships in SERAM, SENR, and ESR, alongside her role as a reviewer for Radiología, underscore her professional dedication to the advancement of radiological science. A visionary researcher and educator, she continues to contribute to training programs for medical imaging professionals, fostering innovation and excellence in radiological education. In conclusion, Assoc. Prof. Dr. Mar Jimenez de la Pena exemplifies a perfect blend of clinical expertise, academic leadership, and research innovation, making her a highly deserving candidate for international recognition in medical imaging and radiological research. Her continued contributions promise to shape the future of neuroimaging and radiodiagnostic excellence globally.

Profile: ORCID

Featured Publications

Jimenez de la Pena, M. (2023). Tatton‐Brown–Rahman syndrome: Novel pathogenic variants and new neuroimaging findings. American Journal of Medical Genetics Part A. Citations: 12
Jimenez de la Pena, M. (2023). White-matter lesions and cortical cerebral blood flow evaluation by 3D arterial spin-labeled perfusion MRI in asymptomatic divers: Correlation with patent foramen ovale occurrence. Journal of Clinical Medicine. Citations: 18
Jimenez de la Pena, M. (2022). Development of a super-resolution scheme for pediatric magnetic resonance brain imaging through convolutional neural networks. Frontiers in Neuroscience. Citations: 25
Jimenez de la Pena, M. (2022). Mutations in the COL18A1 gene associated with Knobloch syndrome and structural brain anomalies: A novel case report and literature review of neuroimaging findings. Neurocase. Citations: 9
Jimenez de la Pena, M. (2021). Neuroimaging findings in patients with EBF3 mutations: Report of two cases. Molecular Syndromology. Citations: 7
Jimenez de la Pena, M. (2021). Abnormal frontal gyrification pattern and uncinate development in patients with KBG syndrome caused by ANKRD11 aberrations. European Journal of Paediatric Neurology. Citations: 15
Jimenez de la Pena, M. (2020). Automatic identification of atypical clinical fMRI results. Neuroradiology. Citations: 22

Muhammad Tahir Aleem | Medicine and Health Sciences | Best Researcher Award

Published on 04/10/202506/10/2025 by Research Hypothesis

Mr. Muhammad Tahir Aleem | Medicine and Health Sciences | Best Researcher Award

Researcher | Shantou University Medical College | China

Mr. Muhammad Tahir Aleem is an accomplished veterinary scientist and postdoctoral researcher recognized for his significant contributions to Preventive Veterinary Medicine, Molecular Parasitology, and Infectious Disease Research. He has developed a strong interdisciplinary foundation that bridges veterinary and biomedical sciences through his extensive global academic and research journey. Mr. Muhammad Tahir Aleem earned his Doctor of Veterinary Medicine (DVM) and M.Phil. in Parasitology from the University of Agriculture, Faisalabad, Pakistan, followed by a Ph.D. in Preventive Veterinary Medicine from Nanjing Agricultural University, China, where his research focused on molecular and immunological aspects of parasitic infections. He further enhanced his expertise through postdoctoral research in Molecular Parasitology and Chromosome Biology at Cleveland State University, USA, and Basic Medicine at Shantou University Medical College, China. His educational background reflects a continuous pursuit of scientific excellence and innovation in veterinary and biomedical disciplines. Professionally, Mr. Muhammad Tahir Aleem is affiliated with the MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, where he actively contributes to research and mentorship in the fields of parasitology, immunology, and infectious diseases. Throughout his academic journey, he has collaborated with international research teams from the United States, China, and Pakistan, focusing on drug development, molecular diagnostics, immunological responses, vaccine development, and zoonotic disease prevention. His research endeavors aim to bridge the gap between human and animal health through innovative molecular and immunological techniques. Mr. Muhammad Tahir Aleem has authored 71 documents, received 519 citations, and holds an h-index of 11, demonstrating his impactful contribution to global scientific literature. His publications in high-impact journals such as Vaccines, Frontiers in Immunology, International Immunopharmacology, and Biomedical Research International reflect his dedication to advancing molecular parasitology and preventive medicine.

Profile: Google scholar | Scopus

Featured Publications

Aleem, M. T., Jiawen, S., Qing Yu, Z., Wen, Z., Yang, Z., & Yan, R. (2021). Characterization of membrane-associated progesterone receptor component-2 (MAPRC2) from Trichinella spiralis and its interaction with progesterone and mifepristone. Vaccines, 9, 934. (Citations: 42)
Aleem, M. T., Khan, A., Wen, Z., Yu, Z., Kun, L., & Cheng, C. (2022). Molecular docking and in silico simulation of Ts-MAPRC2 and its interaction with human-progesterone membrane component-1 (H-PGRMC1). Biomedical Research International. (Citations: 33)
Aleem, M. T., Munir, F., Shakoor, A., & Gao, F. (2024). mRNA vaccines against infectious diseases and future direction. International Immunopharmacology, 135, 112320. (Citations: 27)
Aleem, M. T., Mohsin, M., Shahid, Z., & Ijaz, A. (2023). A review on recent advancement in the molecular diagnostics of Leishmania. Journal of Hellenic Veterinary Medical Society, 74, 5551–5568. (Citations: 12)
Shaukat, A., Aleem, M. T., Munir, F., & Gao, F. (2025). An overview of the role of steroid hormones in various parasitic infections. Journal of Reproductive Immunology, 169, 104533. (Citations: 8)

Ahsan Khurshid | Medicine and Health Sciences | Best Researcher Award

Published on 29/09/2025 by Research Hypothesis

Dr. Ahsan Khurshid | Medicine and Health Sciences | Best Researcher Award

Postgraduate Resident | Quaid-e-Azam Medical College | Pakistan

Dr. Ahsan Khurshid is a committed medical doctor and resident nephrologist at Quaid-e-Azam Medical College, Bahawalpur, who has established himself as an emerging clinical researcher with a passion for improving patient outcomes and advancing the practice of medicine. His education includes an MBBS degree with a strong foundation in medical sciences, followed by specialized residency training in nephrology, equipping him with extensive knowledge of kidney disorders, internal medicine, and evidence-based treatment protocols. Professionally, Dr. Ahsan Khurshid has been deeply engaged in the diagnosis and management of critical and rare medical conditions, including postpartum acute kidney injury, Castleman disease complicating systemic lupus erythematosus, and dengue fever with atypical presentations such as unilateral massive hemothorax. His research interests lie in nephrology, public health, clinical case reporting, and quality improvement projects that enhance hospital systems and patient care. He has successfully led and contributed to multiple clinical audits and quality improvement initiatives such as safe and effective patient handover and oxygen therapy administration according to British Thoracic Society guidelines, demonstrating his ability to translate research into real-world impact. Dr. Ahsan Khurshid possesses strong research skills including literature review, clinical data analysis, manuscript preparation, and adherence to international reporting standards for case reports, which have resulted in peer-reviewed publications and conference presentations. His published works include case reports in the Journal of College of Physicians and Surgeons Pakistan Case Reports and Medical Reports, as well as conference papers presented at the 38th Annual Congress of the Malaysian Society of Nephrology, contributing to the global dissemination of knowledge on rare disease presentations and clinical management. His awards and honors include recognition as a nominee for the Best Researcher Award for his contributions to case report literature and quality improvement projects, alongside memberships in prestigious organizations such as the American Society of Nephrology and the International Society of Nephrology, which enable him to participate in global nephrology discussions and research collaborations. Dr. Ahsan Khurshid continues to advance his academic profile with multiple abstracts and manuscripts in preparation for submission to Q1 indexed journals, aiming to expand his research visibility and impact. In conclusion, Dr. Ahsan Khurshid exemplifies the qualities of a clinician-scientist dedicated to improving healthcare standards through evidence-based practice, interdisciplinary collaboration, and international research engagement, and he is well-positioned to take on future leadership roles in nephrology research, mentorship, and global healthcare initiatives.

Profile: ORCID

Featured Publications

Khurshid, A. (2025). Atypical presentation of dengue fever with unilateral massive hemothorax: A case report. Medical Reports.
Khurshid, A. (2024, July 26–28). Systemic lupus erythematosus complicated with Castleman disease: A case report [Conference presentation]. 38th Annual Congress of Malaysian Society of Nephrology, Kuala Lumpur, Malaysia.
Khurshid, A. (2024). Bombay blood group in a female with postpartum acute kidney injury and sepsis: A case report. Journal of College of Physicians and Surgeons Pakistan Case Reports.
Khurshid, A. (2024). Quality improvement project on safe and effective patient handover in the department of medicine, Bahawal Victoria Hospital, Bahawalpur.
Khurshid, A. (2024). Quality improvement project on prescription and administration of oxygen therapy according to British Thoracic Society guidelines, Department of Medicine, Bahawal Victoria Hospital, Bahawalpur.

Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Published on 16/09/202516/09/2025 by Research Hypothesis

Dr. Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Visiting Faculty | Stanford University | United States

Dr. Shahar Lev-Ari is an accomplished academic with a strong educational foundation in cellular biology and medicine who has over many years built a distinguished career in health promotion, public health research, integrative medicine, and well-being interventions; Dr. Shahar Lev-Ari was trained in cellular biology and obtained his PhD after rigorous work in integrative medicine and intervention science, and his education included advanced training in health promotion science and mindfulness-based behavior change. In his professional experience, Dr. Shahar Lev-Ari has served as founding director of the Integrative Medicine Center & Laboratory of Medicinal Herbs and Cancer Research at the Institute of Oncology, led the Health Promotion Unit within the Integrated Cancer Prevention Center at Tel Aviv Medical Center, and formerly chaired the Department of Health Promotion, School of Public Health at Tel Aviv University; he is also a visiting scholar in Stanford University’s Department of Genetics and collaborates internationally in precision health and psychosocial interventions. Research interests of Dr. Shahar Lev-Ari focus on mindfulness and stress-reduction techniques, inquiry-based stress reduction (IBSR), salutogenesis, resilience, psychosocial health, mental well-being, interventions in at-risk populations (e.g. women with BRCA variants), longevity and protective behavioral and psychosocial factors, mind-body medicine, and digital health tools for well-being. He has developed skills in both quantitative and intervention research; expertise in randomized clinical trials, longitudinal cohort studies, psychosocial measurement, sleep assessments, behavior change, developing and evaluating interventions, public health promotion, multi-disciplinary collaborators, mixed-methods, psychosocial biometrics, and implementing rigorous designs. Dr. Shahar Lev-Ari has been recognized with awards and honours such as the Outstanding Scientist Award from the Israel Society for Complementary Medicine under the auspices of the Israeli Medical Association, and has received support from organizations such as the Rothschild Foundation, the Israeli Cancer Association, and chief scientists in education and medicine; he has also been invited to serve on editorial boards (e.g., Section Editor for Public Health in Journal of Clinical Medicine), and in national and global working groups on mental health promotion. In his published record, Dr. Shahar Lev-Ari has authored 81 documents, has accumulated 2,106 citations, and has h-index 22, demonstrating both breadth and impact. Overall, Dr. Shahar Lev-Ari embodies a scholar-practitioner who bridges fundamental biology, public health, psychosocial interventions and community health implementation, with leadership roles in research, mentorship, and translation of findings into interventions that improve psychological well-being and health outcomes in both general and vulnerable populations.

Profile: Scopus | ORCID

Featured Publications

Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial — 2021; ~3 citations
The Association Between the Sense of Coherence and the Self-Reported Adherence to Guidelines During the First Months of the COVID-19 Pandemic in Israel — 2022; number of citations
The Use of Smart Devices for Mental Health Diagnosis and Care — 2022; number of citations
A Novel Platform for Attenuating Immune Hyperactivity Using EXO-CD24 in COVID-19 and Beyond — 2022; number of citations
Data From a One-Stop-Shop Comprehensive Cancer Screening Center — 2023; number of citations
Mental Health for All: The Case for Investing in Digital Mental Health to Improve Global Outcomes, Access, and Innovation in Low-Resource Settings — 2023; number of citations

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Published on 24/04/202524/04/2025 by Research Hypothesis

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Yuanli Zhang, Chongqing Three Gorges Medical College, China

Assoc. Prof. Dr. Yuanli Zhang is a distinguished academic and the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🇨🇳. With over a decade of dedication to the field of oral biomechanics 🦷🧠, he has significantly advanced knowledge in orthodontics, implantation, and jaw surgery. Dr. Zhang has published more than 20 peer-reviewed papers 📚 and is a lead contributor to several innovative research projects focused on temporomandibular joint (TMJ) dysfunction, integrating engineering and medicine 🤖🧪. He also holds multiple national patents 🧾, reflecting his innovative work in dental biomechanics and medical imaging. His scholarly books, including one published by CRC Press, are used widely in the field. Dr. Zhang’s commitment to research excellence, innovation, and education marks him as a leading figure in biomedical engineering and dental science 🏅.

Publication Profile

Orcid

Education

Dr. Yuanli Zhang holds a rigorous academic background in biomechanics and medical engineering ⚙️🩺. He completed his undergraduate and postgraduate studies in biomedical-related disciplines, focusing on musculoskeletal system analysis and oral-maxillofacial biomechanics. His expertise has been deepened through advanced studies in computational modeling and finite element analysis 💻📐. Dr. Zhang’s education combines theoretical knowledge with hands-on research experience, especially in the simulation and mechanical evaluation of the temporomandibular joint (TMJ). He has also received extensive training in the application of ABAQUS finite element software, which he later translated into a best-selling textbook. His academic formation laid a strong foundation for multidisciplinary collaboration across medicine, dentistry, and mechanical engineering 🤝. This comprehensive educational pathway has empowered him to design and execute complex research projects and contribute meaningfully to both clinical and academic communities 🏫📖.

Experience

Assoc. Prof. Dr. Yuanli Zhang currently serves as the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🏫. With over ten years of research and academic leadership experience, he specializes in oral biomechanics, integrating clinical insights with mechanical engineering principles 🦷⚙️. He has directed numerous research projects on TMJ dysfunction, prosthodontics, and jaw surgery, often collaborating across departments and disciplines 🌐. Dr. Zhang is also a consultant in industrial biomechanics projects involving denture material strength testing and fatigue performance evaluation 🔍🧪. In addition to his administrative duties, he regularly mentors students, coordinates research labs, and publishes in high-impact journals. His dual role in academia and applied research makes him a valuable contributor to innovations in oral healthcare, implantology, and diagnostic imaging technologies 📊🧠.

Awards and Honors

Dr. Zhang’s trailblazing work in oral biomechanics has been recognized through numerous patents and academic accolades 🥇. His book Computational Biomechanics of the Musculoskeletal System is a highly cited reference in the field and showcases his authority on the subject 📘. He was awarded national patents for innovations such as MRI examination aids, implant prosthetics, and medical imaging equipment 🔬📸. These inventions reflect his problem-solving approach to real-world medical challenges. Dr. Zhang has also been honored for his role in translational research, converting complex engineering principles into practical clinical tools. While formal award citations may not be listed, his prolific publication record, interdisciplinary collaborations, and contributions to medical device development are evidence of his scholarly excellence and research leadership 💡🏅. His profile stands strong for the Best Researcher Award based on both innovation and academic impact.

Research Focus

Dr. Yuanli Zhang’s research centers on the biomechanical dynamics of the temporomandibular joint (TMJ) and the clinical implications of dental procedures such as implantation, prosthodontics, and jaw surgeries 🦷🔍. His work bridges engineering mechanics and oral medicine, offering critical insights into TMJ dysfunction caused by surgical interventions or prosthetic usage 🧠⚙️. Utilizing advanced finite element analysis (FEA) and 3D modeling software, Dr. Zhang evaluates stress distributions, joint morphology, and bite force dynamics 💻📊. His research has clinical relevance in reducing patient discomfort, improving surgical outcomes, and guiding personalized treatment planning. Ongoing projects include exploring GDF11 expression in cancer, the effect of implants on TMJ health, and the design of more adaptive oral prosthetics 🧬🧪. His interdisciplinary methodology supports innovations in diagnostic tools and therapeutic strategies, making his research both timely and transformative for the field of biomedical engineering and dental science.

Publication Top Notes

The Effect of Dental Implant Restoration on the Biomechanics of the Temporomandibular Joint in Patients with Posterior Tooth Loss: A Pilot Study

The impact of posterior tooth loss on the biomechanics of the temporomandibular joints

Morphological study of the changes after sagittal split ramus osteotomy in patients with facial asymmetry: measurements of 3-dimensional modelling

Comparison of Morphologic Parameters of Temporomandibular Joint for Asymptomatic Subjects Using the Two-Dimensional and Three-Dimensional Measuring Methods

Morphologic analysis of the temporomandibular joint between patients with facial asymmetry and asymptomatic subjects by 2D and 3D evaluation: A preliminary study

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on 23/04/202523/04/2025 by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on 16/04/202516/04/2025 by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.